V. Michael Holers
Director/Board Member at Q32 Bio, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dave Grayzel | M | 56 |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | - |
| Joseph Flood | M | - |
American College of Rheumatology Research & Education Fdn
 American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Audrey Uknis | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Bill Lundberg | M | 60 |
Taligen Therapeutics, Inc.
 Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts.
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | 3 years |
| Ellen Gravallese | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Jodie Morrison | F | 48 |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | 2 years |
| Joan Marie von Feldt | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| George Hank Brown | M | 84 |
The University of Colorado
| 19 years |
| Renae Cormier | F | 52 |
The University of Colorado
| 1 years |
| Alexa Newlin | F | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Shelia Violette | M | - |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | 7 years |
| Deborah Dyett Desir | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Douglas White | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Abby Abelson | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Samantha Rasnake | F | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Amy B. Miller | F | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Lauren Landreth | F | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Steven Echard | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Melissa Francisco | F | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Amy Fore | F | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Robert A. Colbert | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Alan Weimer | M | - |
The University of Colorado
| - |
| Jan K. Richardson | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Chan H. Pollock | M | - |
The University of Colorado
| - |
| Sharon Bakke | F | - |
The University of Colorado
| - |
| Heather Haugen | M | - |
The University of Colorado
| - |
| Heidi A. Ganahl | F | - |
The University of Colorado
| - |
| Leigh Callahan | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| George A. Sissel | M | 87 |
The University of Colorado
| - |
| Gary S. Firestein | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Peter Mariner | M | - |
The University of Colorado
| - |
| Lauren Shaner | F | - |
The University of Colorado
| - |
| Eric L. Matteson | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Simon Read | M | 53 |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | 3 years |
| John W. Birks | M | - |
The University of Colorado
| - |
| Jason A. Campagna | M | 54 |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | - |
| Michael Gladstone | M | 37 |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | - |
| Stephen R. Daniels | M | - |
The University of Colorado
| - |
| Michael S. Anger | M | - |
The University of Colorado
| - |
| Mark A. Wickert | M | - |
The University of Colorado
| - |
| Maura Iversen | F | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| David R. Laube | M | - |
The University of Colorado
| - |
| Leslie Leinwand | M | - |
The University of Colorado
| - |
| Chris Bowman | M | - |
The University of Colorado
| - |
| Kristi S. Anseth | M | - |
The University of Colorado
| - |
| Robin Shandas | M | - |
The University of Colorado
| - |
| Brian Gallagher | M | 54 |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | - |
| Katherine S. Upchurch | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Gregg Silverman | M | - |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | - |
| Patricia Nelson Limerick | F | - |
The University of Colorado
| - |
| Marcelo R. Bergquist | M | - |
The University of Colorado
| - |
| Michael C. Mozer | M | - |
The University of Colorado
| - |
| Marvin H. Caruthers | M | 84 |
The University of Colorado
| 45 years |
| Richard D. Krugman | M | - |
The University of Colorado
| - |
| John P. Raeder | M | - |
The University of Colorado
| - |
| Misha Plam | M | - |
The University of Colorado
| - |
| Richard Duke | M | - |
The University of Colorado
| - |
| Garret Moddel | M | - |
The University of Colorado
| - |
| Shelley Chu | M | 54 |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | - |
| Craig W. Donaldson | M | - |
The University of Colorado
| - |
| Thomas Robert Cech | M | 76 |
The University of Colorado
| 34 years |
| John R. Woodhull | M | 90 |
The University of Colorado
| - |
| Larry Gold | M | 82 |
The University of Colorado
| 54 years |
| Errol L. Biggs | M | 83 |
The University of Colorado
| - |
| Richard Abrams | M | - |
The University of Colorado
| - |
| Kathy LaPorte | F | 62 |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | 3 years |
| Stephen P. Squinto | M | 67 |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | - |
| Michael D. Iseman | M | 85 |
The University of Colorado
| 44 years |
| Joe M. McCord | M | 79 |
The University of Colorado
| - |
| David L. Braddock | M | 79 |
The University of Colorado
| 23 years |
| George P. Sape | M | 79 |
The University of Colorado
| - |
| James Rothe | M | 80 |
The University of Colorado
| 38 years |
| Betty Arkell | F | - |
The University of Colorado
| - |
| Donald Bellgrau | M | - |
The University of Colorado
| - |
| Dale N. Hatfield | M | 86 |
The University of Colorado
| 23 years |
| John F. Carpenter | M | - |
The University of Colorado
| - |
| Alan Greenberg | M | - |
The University of Colorado
| - |
| Jeff Saywitz | M | - |
The University of Colorado
| - |
| Richard Lee Lewis | M | - |
The University of Colorado
| - |
| Sandy Hicks | F | - |
The University of Colorado
| - |
| Benjamin C. Schnell | M | - |
The University of Colorado
| - |
| Edward J. Weiler | M | - |
The University of Colorado
| - |
| Raul Guisado | M | - |
The University of Colorado
| - |
| Betty R. Jackson | M | - |
The University of Colorado
| - |
| Ryan T. Gill | M | - |
The University of Colorado
| 23 years |
| Mark Iwicki | M | 57 |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | 4 years |
| David Secunda | M | - |
The University of Colorado
| - |
| Wayne F. Cascio | M | - |
The University of Colorado
| - |
| James Ehrlich | M | - |
The University of Colorado
| - |
| David Grooms | M | - |
The University of Colorado
| - |
| Michael B. Guthrie | M | - |
The University of Colorado
| - |
| Christopher Staszak | M | - |
The University of Colorado
| - |
| Christopher Ozeroff | M | 65 |
The University of Colorado
| - |
| William Barker | M | 75 |
The University of Colorado
| 16 years |
| Melissa Gonzales | F | - |
The University of Colorado
| - |
| Paul Terrence O'Rourke | M | - |
The University of Colorado
| - |
| Janet Pritchard | F | - |
The University of Colorado
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Abbie Celniker | M | 65 |
Taligen Therapeutics, Inc.
Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | 3 years |
| James Woodruff Emlen | M | - |
Taligen Therapeutics, Inc.
Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | 8 years |
| Timothy C. Mills | M | 68 |
Taligen Therapeutics, Inc.
Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- V. Michael Holers
- Personal Network
